For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...

India hosted the 16th BRICS Health Ministers' Meeting in Chandigarh. The meeting established a network for mental wellness research and col...

Serum Institute will manufacture an experimental tuberculosis vaccine. This novel vaccine candidate is currently in late-stage clinical tri...

MTBVAC, the TB vaccine, has undergone Phase I and II clinical trials in India. The vaccine has demonstrated safety and immunogenicity. Base...

Scientists at Massachusetts Institute of Technology (MIT) are developing a next-generation vaccine to combat tuberculosis (TB), one of the ...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine enhances immunity...

Kansas is experiencing the biggest TB outbreak in American history. So far, KDHE confirmed 67 active and 79 latent cases in the state.

The only vaccine in use today--BCG (Bacillus Calmette and Guerin)--is an attenuated variant of the bovine TB pathogen. This is more than a ...

Bharat Biotech International Ltd has initiated clinical trials for the Tuberculosis vaccine Mtbvac on adults in India. Developed by the Spa...

According to the India TB Report 2022, the number of 'incident TB patients' (new and relapse cases) notified during 2021 stood at 19.3 lakh...

The EUA application was submitted on March 22 by Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute ...

The new TB vaccine, 'MTBVAC', is being manufactured and developed by Biofabri, in close collaboration with the University of Zaragoza, IAVI...

Bacillus Calmette-Guerin (BCG) vaccine, used to protect against tuberculosis, induces a broad innate immune-system response and has been sh...

VPM1002, a tuberculosis vaccine, is showing encouraging results against the coronavirus infection in phase-III clinical trials being conduc...

The new vaccine, known as M72/AS01E, was tested at 11 sites in Kenya, South Africa and Zambia in adults whose blood tests showed they had l...

Scientists have found that a variant of an existing vaccine offers stronger protection against both tuberculosis and leprosy.